why would BIOL search for a distributor and why would a distributor climb on board after schein fiasco? doesnt schein have a medical distribution side? seems to me that some shortsighted moves have been made over the last couple years.
True, but Biolase has yet to tell the shareholders why anyone be willing to pony up the cash and the time to developa system that might actually make money. What un met need will it provide. Can it perform existing proceedure better or for less cost? Won't Freddie tell us it he knew?
In general, I think revenue growth an ongoing story for BIOL, in that regard I see short interest increasing which could actually act as a catalyst. The latest number of 2.8 million shares will take 2 weeks to cover with average volume. When a good report comes out in May they will have to pace themselves, or risk pushing price up on increased volume / demand from covering. Since it's an ongoing growth story anyone waiting to cover risks max pain, but the short squeeze will add some volitility to that moment, and shorts will try to regain losses by shorting the spike. Some will time it correctly others will not. Longs can just enjoy the repeating pattern for a while.
Management projects a "modest" 18% growth for 2013 with Q1 guidance of 14-15 M, follow that number for the short term play. Other than that there are patents still pending, and markets BIOL will be pushing in to, but I see those as a progression, not binary events. Though news from any of that could make a pop here or there.
Makeing money would be a great catalyst. Why did Freddie prepare us for more loses in the 4Q12 CC? I guess he doesn't think it will happen. What would the "growth rate" for 4Q12 have been with out Schein's refurbished MD sales?